Physician profile
Tom C Yu
NPI 1437165214
$743.89
in general payments reported to CMS, 2019-2025
11 companies · $193 in 2025
The $193 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $145 · 2023: $53.73 · 2024: $82.41 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $145.74 | 2019 | |
| Mallinckrodt Hospital Products INC. | $144.55 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $93.99 | 2019 | |
| Abbvie INC. | $83.53 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.14 | 2025 | Entyvio |
| Janssen Biotech, INC. | $56.17 | 2023-2024 | Stelara |
| Aimmune Therapeutics, INC. | $31.77 | 2025 | Zenpep |
| Lilly USA, LLC | $30.38 | 2024 | Omvoh |
| Ge Healthcare | $30.03 | 2019 | |
| Ardelyx, INC. | $28.59 | 2024 | Ibsrela |
| Genzyme Corporation | $21.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.